- Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: identification of (S)-N-[1-(4-fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibition. Wu, Y.J., Davis, C.D., Dworetzky, S., Fitzpatrick, W.C., Harden, D., He, H., Knox, R.J., Newton, A.E., Philip, T., Polson, C., Sivarao, D.V., Sun, L.Q., Tertyshnikova, S., Weaver, D., Yeola, S., Zoeckler, M., Sinz, M.W. J. Med. Chem. (2003)









